www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 22), pp: 35984-36000 Research Paper Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics Shu-Juan Wang1,*, Ping-Zhang Wang2,*, Robert Peter Gale3, Ya-Zhen Qin1, Yan- Rong Liu1, Yue-Yun Lai1, Hao Jiang1, Qian Jiang1, Xiao-Hui Zhang1, Bin Jiang1, Lan- Ping Xu1, Xiao-Jun Huang1,4, Kai-Yan Liu1, Guo-Rui Ruan1 1Peking University People’s Hospital and Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China 2Department of Immunology, School of Basic Medical Sciences, Peking University Health Science Center, Key Laboratory of Medical Immunology, Ministry of Health, China, Peking University Center for Human Disease Genomics, Beijing, China 3Hematology Research Center, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK 4Peking-Tsinghua Center for Life Sciences, Beijing, China *These authors contributed equally to this work Correspondence to: Kai-Yan Liu, email:
[email protected] Guo-Rui Ruan, email:
[email protected] Keywords: acute lymphoblastic leukemia, CSRP2, prognostic factor, relapse, drug resistance Received: December 10, 2016 Accepted: March 11, 2017 Published: March 21, 2017 Copyright: Wang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Relapse is the major cause of treatment-failure in adults with B-cell acute lymphoblastic leukemia (ALL) achieving complete remission after induction chemotherapy.